Cite
MLA Citation
et al.. “Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.” Lancet, vol. 399, no. 10324, 2022, pp. 530–540. http://access.bl.uk/ark:/81055/vdc_100150533914.0x000055